Jacob Levman1. 1. Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK. Imaging Research, Sunnybrook Research Institute, University of Toronto , Toronto, Ontario, Canada .
Abstract
CONTEXT: This study presents a longitudinal simulation of disease screening at a variety of different test sensitivities. AIMS: It is demonstrated that the difference between the performance of high quality tests and poor quality tests are relatively small in terms of the commonly used longitudinally measured disease detection rate. STATISTICAL ANALYSIS: This simulation study is focused on the screening of patients at high-risk for breast cancer and thus used plausible rates of new cases of disease and initial disease prevalence for this population. RESULTS AND CONCLUSIONS: The effects of varying the rate at which the disease enters the population and the initial disease prevalence is also discussed and was determined to not affect this study's conclusions regarding the inappropriateness of the use of the longitudinally measured disease detection rate for the evaluation of screening technologies.
CONTEXT: This study presents a longitudinal simulation of disease screening at a variety of different test sensitivities. AIMS: It is demonstrated that the difference between the performance of high quality tests and poor quality tests are relatively small in terms of the commonly used longitudinally measured disease detection rate. STATISTICAL ANALYSIS: This simulation study is focused on the screening of patients at high-risk for breast cancer and thus used plausible rates of new cases of disease and initial disease prevalence for this population. RESULTS AND CONCLUSIONS: The effects of varying the rate at which the disease enters the population and the initial disease prevalence is also discussed and was determined to not affect this study's conclusions regarding the inappropriateness of the use of the longitudinally measured disease detection rate for the evaluation of screening technologies.
Entities:
Keywords:
Breast Cancer; Disease Screening; Longitudinal Studies; Technology Assessment
Authors: Steven G Lee; Susan G Orel; Irene J Woo; Eva Cruz-Jove; Mary E Putt; Lawrence J Solin; Brian J Czerniecki; Mitchell D Schnall Journal: Radiology Date: 2003-01-31 Impact factor: 11.105
Authors: Lawrence J Solin; Susan G Orel; Wei-Ting Hwang; Eleanor E Harris; Mitchell D Schnall Journal: J Clin Oncol Date: 2008-01-20 Impact factor: 44.544
Authors: Constance D Lehman; Constantine Gatsonis; Christiane K Kuhl; R Edward Hendrick; Etta D Pisano; Lucy Hanna; Sue Peacock; Stanley F Smazal; Daniel D Maki; Thomas B Julian; Elizabeth R DePeri; David A Bluemke; Mitchell D Schnall Journal: N Engl J Med Date: 2007-03-28 Impact factor: 91.245
Authors: Ellen Warner; Donald B Plewes; Kimberley A Hill; Petrina A Causer; Judit T Zubovits; Roberta A Jong; Margaret R Cutrara; Gerrit DeBoer; Martin J Yaffe; Sandra J Messner; Wendy S Meschino; Cameron A Piron; Steven A Narod Journal: JAMA Date: 2004-09-15 Impact factor: 56.272